FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Prescript Pharmaceuticals Acetaminophen 300 mg with Codeine Phosphate Recall

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containe…

Prescript Pharmaceuticals, Inc. · Pleasanton, CA

Risk level
Class II
Reported by FDA
May 23, 2018
Recall ID
D-0806-2018
Check your lot numberHow we source this data

Summary

Prescript Pharmaceuticals recalled Acetaminophen 300 mg with Codeine Phosphate starting Apr 24, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0806-2018 on May 23, 2018. Reason: Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F). Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Product description

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. Mnfct by: Aurolife Pharma LLC, Dayton, NJ 08810. Pckgd by PreScript Pharm Inc. Pleasanton, CA 94566. NDC: 13107-059-99 Bar Code 0078-20-2033

Lot numbers, UPCs & expiration codes

Lot # 0130131, EXP 8/31/20

Where it was sold

California.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0806-2018
Classification
Class II
Status
Terminated
Recall initiated
Apr 24, 2018
FDA report date
May 23, 2018
Quantity
1 20-count containers
Recall type
Voluntary: Firm initiated
Recalling firm
Prescript Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0806-2018, exactly as published.

Show all FDA fields
City
Pleasanton
State
CA
Status
Terminated
Country
United States
Event ID
79961
Address
39 California Ave Ste 104
Code information
Lot # 0130131, EXP 8/31/20
Postal code
94566-6279
Report date
May 23, 2018
Product type
Drugs
Recall number
D-0806-2018
Classification
Class II
Recalling firm
Prescript Pharmaceuticals, Inc.
Product quantity
1 20-count containers
Termination date
Jan 23, 2019
Reason for recall
Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. Mnfct by: Aurolife Pharma LLC, Dayton, NJ 08810. Pckgd by PreScript Pharm Inc. Pleasanton, CA 94566. NDC: 13107-059-99 Bar Code 0078-20-2033
Distribution pattern
California.
Recall initiation date
Apr 24, 2018
Initial firm notification
Letter
Center classification date
May 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0806-2018, published May 23, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls